We combine computational and genomic approaches to study the impact of microbes on human health. These microbes include bacterial pathogens such as Neisseria gonorrhea, the causative agent of gonorrhea, as well as parasites such as Toxoplasma gondii, Plasmodium falciparum, and Brugia malayi the causative agents of toxoplasmosis, malaria and elephantiasis respectively. We also study the role of complex microbial communities (microbiomes) in a host of chronic diseases including obesity, inflammatory bowel disease and malnutrition. Key to these analyses are “systems-based” methods, such as metabolic modelling and network biology, that allow us to understand how genes are organized into the biochemical pathways that drive infection. Application of these methods has allowed the identification of novel drug targets, helping drive the development of novel therapeutics that are urgently needed to combat the rise of antimicrobial resistance.
We look at a wide range of microbial communities including the poultry gut microbiome, human gut microbiome and the vaginal microbiome.
We study parasites such as Toxoplasma and Trichomonas, which have ramifications for the health of billions of people.
We develop in-house pipelines and tools that offer noval methods to the bioinformatics field.